mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.2 |
mRNA |
1S,3R-RSL-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
BRD-K50799972 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.2 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.2 |